vs

Side-by-side financial comparison of IT TECH PACKAGING, INC. (ITP) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $25.6M, roughly 1.7× IT TECH PACKAGING, INC.). IT TECH PACKAGING, INC. runs the higher net margin — -5.7% vs -90.4%, a 84.8% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs 2.1%). IT TECH PACKAGING, INC. produced more free cash flow last quarter ($1.5M vs $-19.9M). Over the past eight quarters, IT TECH PACKAGING, INC.'s revenue compounded faster (10.5% CAGR vs 7.3%).

IT TECH PACKAGING, INC. is a paper manufacturing enterprise primarily operating in China. It produces and distributes a diverse portfolio of paper products including corrugated packaging paper, boxboard, and printing-use cultural paper, serving sectors such as consumer goods packaging, logistics, and commercial printing across its core market.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

ITP vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.7× larger
PACB
$44.6M
$25.6M
ITP
Growing faster (revenue YoY)
PACB
PACB
+11.7% gap
PACB
13.8%
2.1%
ITP
Higher net margin
ITP
ITP
84.8% more per $
ITP
-5.7%
-90.4%
PACB
More free cash flow
ITP
ITP
$21.4M more FCF
ITP
$1.5M
$-19.9M
PACB
Faster 2-yr revenue CAGR
ITP
ITP
Annualised
ITP
10.5%
7.3%
PACB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ITP
ITP
PACB
PACB
Revenue
$25.6M
$44.6M
Net Profit
$-1.4M
$-40.4M
Gross Margin
7.9%
37.1%
Operating Margin
-3.9%
-92.3%
Net Margin
-5.7%
-90.4%
Revenue YoY
2.1%
13.8%
Net Profit YoY
26.6%
-1802.7%
EPS (diluted)
$-0.11
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ITP
ITP
PACB
PACB
Q4 25
$44.6M
Q3 25
$25.6M
$38.4M
Q2 25
$24.8M
$39.8M
Q1 25
$10.9M
$37.2M
Q4 24
$17.6M
$39.2M
Q3 24
$25.1M
$40.0M
Q2 24
$26.2M
$36.0M
Q1 24
$6.9M
$38.8M
Net Profit
ITP
ITP
PACB
PACB
Q4 25
$-40.4M
Q3 25
$-1.4M
$-38.0M
Q2 25
$-2.0M
$-41.9M
Q1 25
$-3.5M
$-426.1M
Q4 24
$-4.0M
$2.4M
Q3 24
$-2.0M
$-60.7M
Q2 24
$-77.7K
$-173.3M
Q1 24
$-3.7M
$-78.2M
Gross Margin
ITP
ITP
PACB
PACB
Q4 25
37.1%
Q3 25
7.9%
41.4%
Q2 25
5.1%
36.9%
Q1 25
0.8%
-3.7%
Q4 24
6.3%
25.6%
Q3 24
7.6%
25.0%
Q2 24
12.4%
16.5%
Q1 24
5.8%
29.1%
Operating Margin
ITP
ITP
PACB
PACB
Q4 25
-92.3%
Q3 25
-3.9%
-101.1%
Q2 25
-7.1%
-112.8%
Q1 25
-31.0%
-1154.5%
Q4 24
-21.5%
-390.1%
Q3 24
-5.8%
-160.3%
Q2 24
2.1%
-488.3%
Q1 24
-51.0%
-209.6%
Net Margin
ITP
ITP
PACB
PACB
Q4 25
-90.4%
Q3 25
-5.7%
-98.9%
Q2 25
-7.9%
-105.4%
Q1 25
-32.2%
-1146.8%
Q4 24
-22.9%
6.0%
Q3 24
-7.9%
-151.9%
Q2 24
-0.3%
-481.3%
Q1 24
-54.6%
-201.4%
EPS (diluted)
ITP
ITP
PACB
PACB
Q4 25
$-0.11
Q3 25
$-0.11
$-0.13
Q2 25
$-0.16
$-0.14
Q1 25
$-0.35
$-1.44
Q4 24
$-0.40
$-0.44
Q3 24
$-0.20
$-0.22
Q2 24
$-0.01
$-0.64
Q1 24
$-0.37
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ITP
ITP
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$279.5M
Total DebtLower is stronger
$4.7M
Stockholders' EquityBook value
$152.0M
$5.3M
Total Assets
$175.7M
$784.1M
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ITP
ITP
PACB
PACB
Q4 25
$279.5M
Q3 25
$298.7M
Q2 25
$314.7M
Q1 25
$343.1M
Q4 24
$389.9M
Q3 24
$471.1M
Q2 24
$509.8M
Q1 24
$561.9M
Total Debt
ITP
ITP
PACB
PACB
Q4 25
Q3 25
$4.7M
Q2 25
$4.7M
Q1 25
$4.7M
Q4 24
$4.7M
Q3 24
$8.9M
Q2 24
$11.3M
Q1 24
$11.4M
Stockholders' Equity
ITP
ITP
PACB
PACB
Q4 25
$5.3M
Q3 25
$152.0M
$36.1M
Q2 25
$152.3M
$61.5M
Q1 25
$152.8M
$91.6M
Q4 24
$156.1M
$506.6M
Q3 24
$164.3M
$453.1M
Q2 24
$163.5M
$492.7M
Q1 24
$164.3M
$649.0M
Total Assets
ITP
ITP
PACB
PACB
Q4 25
$784.1M
Q3 25
$175.7M
$803.2M
Q2 25
$175.2M
$825.5M
Q1 25
$175.2M
$860.8M
Q4 24
$177.5M
$1.3B
Q3 24
$190.0M
$1.5B
Q2 24
$191.4M
$1.5B
Q1 24
$177.5M
$1.7B
Debt / Equity
ITP
ITP
PACB
PACB
Q4 25
Q3 25
0.03×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.05×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ITP
ITP
PACB
PACB
Operating Cash FlowLast quarter
$1.5M
$-19.1M
Free Cash FlowOCF − Capex
$1.5M
$-19.9M
FCF MarginFCF / Revenue
5.9%
-44.6%
Capex IntensityCapex / Revenue
0.0%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$3.8M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ITP
ITP
PACB
PACB
Q4 25
$-19.1M
Q3 25
$1.5M
$-18.7M
Q2 25
$1.4M
$-29.4M
Q1 25
$-2.5M
$-44.1M
Q4 24
$3.5M
$-30.6M
Q3 24
$1.5M
$-45.5M
Q2 24
$721.9K
$-54.3M
Q1 24
$624.4K
$-75.7M
Free Cash Flow
ITP
ITP
PACB
PACB
Q4 25
$-19.9M
Q3 25
$1.5M
$-18.8M
Q2 25
$1.3M
$-29.9M
Q1 25
$-2.5M
$-45.4M
Q4 24
$3.5M
$-32.3M
Q3 24
$1.2M
$-46.3M
Q2 24
$668.3K
$-55.7M
Q1 24
$615.4K
$-79.6M
FCF Margin
ITP
ITP
PACB
PACB
Q4 25
-44.6%
Q3 25
5.9%
-48.9%
Q2 25
5.4%
-75.3%
Q1 25
-22.8%
-122.3%
Q4 24
19.6%
-82.3%
Q3 24
4.9%
-115.7%
Q2 24
2.5%
-154.8%
Q1 24
9.0%
-205.0%
Capex Intensity
ITP
ITP
PACB
PACB
Q4 25
1.9%
Q3 25
0.0%
0.2%
Q2 25
0.1%
1.4%
Q1 25
0.1%
3.7%
Q4 24
0.1%
4.1%
Q3 24
1.0%
2.0%
Q2 24
0.2%
4.1%
Q1 24
0.1%
10.0%
Cash Conversion
ITP
ITP
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ITP
ITP

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons